Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Daily COMP-4 Supplementation on Brachial Artery Flow Mediated Dilation and Cellular Senescence Markers in Young and Healthy Individuals

NCT05595915 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05595915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Daily COMP-4 Supplementation on Brachial Artery Flow Mediated Dilation and Cellular Senescence Markers in Young and Healthy Individuals
Lead sponsor
University of California, Los Angeles
Phase
Phase 1/2
Overall status
Completed
Start date
June 1, 2023
Completion date
November 22, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, endothelial dysfunction, senescence